Non-ischemic Cardiomyopathy: Role of Immunologic Work-up and ... - JAPI
ischemic cardiomyopathy is usually well evaluated noninvasively using echocardiography, echocardiography is often deficient for characterization of nonischemic cardiomyopathy. Although the first line of therapy for ischemic cardiomyopathy is directed at improving myocardial blood flow in narrowed coronary arteries, such therapy usually has no role in patients with nonischemic cardiomyopathy. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- non ischemic diabetic cardiomyopathy may initially exhibit a transient
- ischemic and non ischemic dilated cardiomyopathy
- patient information non ischemic cardiomyopathy
- accessory pathway mediated cardiomyopathy in severe non ischemic
- non ischemic cardiomyopathies and cardiac mri
- original article ischemic cardiomyopathy versus non ischemic
- non ischemic cardiomyopathy role of immunologic work up and japi
- social inequalities in non ischemic cardiomyopathies
- nuclear imaging in non ischemic cardiomyopathies
- non ischaemic cardiomyopathy sudden death and implantable heart
Related searches
- non ischemic cardiomyopathy life expect
- non ischemic cardiomyopathy life expectancy
- non ischemic cardiomyopathy symptoms
- can non ischemic cardiomyopathy resolve
- non ischemic cardiomyopathy differential
- non ischemic cardiomyopathy causes
- non ischemic cardiomyopathy prognosis
- non ischemic cardiomyopathy icd 10
- non ischemic cardiomyopathy treatment
- non ischemic cardiomyopathy code
- non ischemic cardiomyopathy workup
- non ischemic cardiomyopathy hcc